National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global NK Cell Therapy Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Global NK Cell Therapy Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Goods_sn:kerry-gz3

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global NK Cell Therapy Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Single User License: 3350 USD
Multi User License: 5025 USD
Enterprise License: 6700 USD
Pages: 97
Tables and Figures: 117
Published Date: Aug 2019
Publisher: QYR Medical Care Research Center
Email: sales@qyresearch.com

Summary

To date, they have generated minimal revenue related to the non-clinical use of their cell lines and intellectual property. They have no products approved for commercial sale and have not generated any revenue from product sales.

The global natural killer cells therapeutics market was valued at $216.219 million in 2018, and is projected to reach $626.769 million by 2025, registering a CAGR of 16.4% from 2018 to 2025.

This report studies the NK Cell Therapy market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; this report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the global top players, covered
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech

Market segment by Regions/Countries, this report covers:
North America
Europe
Asia
RoW

Market segment by Type, the product can be split into:
NK Cell Therapies
NK Cell Directed Antibodies

Market segment by Application, the market can be split into:
Cancer
Gastrointestinal Diseases
Others

 
Table of Contents

1 Market Overview of NK Cell Therapy 1
1.1 NK Cell Therapy Market Overview 1
1.1.1 NK Cell Therapy Product Scope 1
1.1.2 NK Cell History 1
1.1.3 Market Status and Outlook 2
1.2 Global NK Cell Therapy Market Size and Analysis by Regions (2014-2019) 3
1.2.1 North America 4
1.2.2 Europe 5
1.2.3 Asia 5
1.2.4 Rest of World 6
1.3 NK Cell Therapy Market by Type 6
1.3.1 Global NK Cell Therapy Revenue (M USD) and Growth Comparison by Type (2014-2025) 7
1.3.2 Global NK Cell Therapy Revenue Market Share by Type in 2018 7
1.3.3 NK Cell Therapies 8
1.3.4 NK Cell Directed Antibodies 9
1.4 NK Cell Therapy Market by End Users/Application 9
1.4.1 Cancer 10
1.4.2 Gastrointestinal Diseases 11
2 Global NK Cell Therapy Competition Analysis by Players 13
2.1 Global NK Cell Therapy Market Size (M USD) by Players (2014-2019) 13
2.2 Competitive Status 16
2.2.1 Market Concentration Rate 16
2.2.2 Product/Service Differences 17
2.2.3 Mergers & Acquisitions, Expansion Plans 18
3 Company (Top Players) Profiles and Key Data 20
3.1 Nektar Therapeutics 20
3.1.1 Nektar Therapeutics Profile 20
3.1.2 Nektar Therapeutics Main Business/Business Overview 20
3.1.3 Nektar Therapeutics NK Cell Therapy Products, Services and Solutions 21
3.1.3.1 Bempegaldesleukin(NKTR-214) 21
3.1.3.2 NKTR-262 22
3.1.3.3 NKTR-255 23
3.1.4 Nektar Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 23
3.1.5 Nektar Therapeutics Recent Developments 24
3.2 Innate Pharma SA 24
3.2.1 Innate Pharma SA Profile 24
3.2.2 Innate Pharma SA Main Business/Business Overview 25
3.2.3 Innate Pharma SA NK Cell Therapy Products, Services and Solutions 25
3.2.3.1 Monalizumab (Previously IPH2201) 25
3.2.3.2 NKP46 NKCE 26
3.2.3.3 IPH4102 26
3.2.4 Innate Pharma SA NK Cell Therapy Revenue (M USD) (2018-2019) 27
3.2.5 Innate Pharma SA Recent Developments 27
3.3 Affimed NV 27
3.3.1 Affimed NV Profile 27
3.3.2 Affimed NV Main Business/Business Overview 28
3.3.3 Affimed NV NK Cell Therapy Products, Services and Solutions 28
3.3.3.1 AFM13 28
3.3.3.2 AFM24 28
3.3.3.3 AFM26 (partnered) 29
3.3.4 Affimed NV NK Cell Therapy Revenue (M USD) (2018-2019) 29
3.3.5 Affimed NV Recent Developments 29
3.4 Chipscreen Biosciences 30
3.4.1 Chipscreen Biosciences Profile 30
3.4.2 Chipscreen Biosciences Main Business/Business Overview 30
3.4.3 Chipscreen Biosciences NK Cell Therapy Products, Services and Solutions 31
3.4.4 Chipscreen Biosciences NK Cell Therapy Revenue (M USD) (2018-2019) 32
3.4.5 Chipscreen Biosciences Recent Developments 32
3.5 Fate Therapeutics 32
3.5.1 Fate Therapeutics Profile 32
3.5.2 Fate Therapeutics Main Business/Business Overview 33
3.5.3 Fate Therapeutics NK Cell Therapy Products, Services and Solutions 33
3.5.3.1 FT500 33
3.5.3.2 NK100 33
3.5.4 Fate Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 34
3.5.5 Fate Therapeutics Recent Developments 34
3.6 Glycostem Therapeutics 34
3.6.1 Glycostem Therapeutics Profile 34
3.6.2 Glycostem Therapeutics Main Business/Business Overview 35
3.6.3 Glycostem Therapeutics NK Cell Therapy Products, Services and Solutions 35
3.6.4 Glycostem Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 36
3.6.5 Glycostem Therapeutics Recent Developments 36
3.7 Dragonfly Therapeutics 37
3.7.1 Dragonfly Therapeutics Profile 37
3.7.2 Dragonfly Therapeutics Main Business/Business Overview 37
3.7.3 Dragonfly Therapeutics NK Cell Therapy Products, Services and Solutions 37
3.7.4 Dragonfly Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 38
3.7.5 Dragonfly Therapeutics Recent Developments 38
3.8 Kiadis Pharma 38
3.8.1 Kiadis Pharma Profile 38
3.8.2 Kiadis Pharma Main Business/Business Overview 39
3.8.3 Kiadis Pharma NK Cell Therapy Products, Services and Solutions 39
3.8.4 Kiadis Pharma NK Cell Therapy Revenue (M USD) (2018-2019) 39
3.8.5 Kiadis Pharma Recent Developments 40
3.9 NantWorks 40
3.9.1 NantWorks Profile 40
3.9.2 NantWorks Main Business/Business Overview 40
3.9.3 NantWorks NK Cell Therapy Products, Services and Solutions 41
3.9.4 NantWorks NK Cell Therapy Revenue (M USD) (2018-2019) 42
3.9.5 NantWorks Recent Developments 42
3.10 Nkarta Therapeutics 42
3.10.1 Nkarta Therapeutics Profile 42
3.10.2 Nkarta Therapeutics Main Business/Business Overview 43
3.10.3 Nkarta Therapeutics NK Cell Therapy Products, Services and Solutions 43
3.10.4 Nkarta Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 44
3.10.5 Nkarta Therapeutics Recent Developments 44
3.11 Fortress Biotech 44
3.11.1 Fortress Biotech Profile 44
3.11.2 Fortress Biotech Main Business/Business Overview 45
3.11.3 Fortress Biotech NK Cell Therapy Products, Services and Solutions 45
3.11.4 Fortress Biotech NK Cell Therapy Revenue (M USD) (2018-2019) 45
3.11.5 Fortress Biotech Recent Developments 46
4 Global NK Cell Therapy Market Size by Application (2014-2019) 47
4.1 Global NK Cell Therapy Market Size by Application (2014-2019) 47
4.2 Global NK Cell Therapy Market Growth by Application 49
4.3 Potential Application of NK Cell Therapy in Future 49
5 North America NK Cell Therapy Development Status and Outlook 50
5.1 North America NK Cell Therapy Market Size (2014-2019) 50
5.2 North America NK Cell Therapy Market Size and Market Share by Players (2018-2019) 50
5.3 North America NK Cell Therapy Market Size by Application (2014-2019) 52
6 Europe NK Cell Therapy Development Status and Outlook 53
6.1 Europe NK Cell Therapy Market Size (2014-2019) 53
6.2 Europe NK Cell Therapy Market Size and Market Share by Players (2018-2019) 53
6.3 Europe NK Cell Therapy Market Size by Application (2014-2019) 54
7 Asia NK Cell Therapy Development Status and Outlook 56
7.1 Asia NK Cell Therapy Market Size and Forecast (2014-2019) 56
7.2 Asia NK Cell Therapy Market Size and Market Share by Players (2018-2019) 56
7.3 Asia NK Cell Therapy Market Size by Application (2014-2019) 57
8 Rest of World NK Cell Therapy Development Status and Outlook 59
8.1 Rest of World NK Cell Therapy Market Size (2014-2019) 59
8.2 Rest of World NK Cell Therapy Market Size by Application (2014-2019) 59
9 Global NK Cell Therapy Market Size by Type (2014-2019) 61
9.1 Global NK Cell Therapy Market Size by Type (2014-2019) 61
9.2 Global NK Cell Therapy Market Growth by Type 62
10 T-cell Therapy and NK Cell Therapy 64
10.1 Cell Therapy Overview 64
10.2 T-cell Therapy Overview 64
10.3 CAR-NK Cells’ Advantages over CAR-T Cells 64
10.4 Source of the NK Cells 65
11 Market Forecast by Regions, Product and Application (2019-2025) 66
11.1 Global NK Cell Therapy Market Size by Regions (2019-2025) 66
11.1.1 North America NK Cell Therapy Revenue and Growth Rate (2019-2025) 69
11.1.2 Europe NK Cell Therapy Revenue and Growth Rate (2019-2025) 70
11.1.3 Asia NK Cell Therapy Revenue and Growth Rate (2019-2025) 71
11.1.4 Rest of World NK Cell Therapy Revenue and Growth Rate (2019-2025) 72
11.2 Global NK Cell Therapy Market Size by Application (2019-2025) 72
11.3 Global NK Cell Therapy Market Size by Type (2019-2025) 74
12 NK Cell Therapy Market Dynamics 76
12.1 Industry Trends 76
12.2 Market Drivers 76
12.3 Market Challenges 77
12.4 Porter’s Five Forces Analysis 77
12.5 NK Cell Developers Analysis 78
13 Research Finding /Conclusion 80
14 Methodology and Data Source 81
14.1 Methodology/Research Approach 81
14.1.1 Research Programs/Design 81
14.1.2 Market Size Estimation 82
14.1.3 Market Breakdown and Data Triangulation 83
14.2 Data Source 85
14.2.1 Secondary Sources 85
14.2.2 Primary Sources 85
14.3 Disclaimer 86
14.4 Author List 87

 

List of Tables and Figures

Figure NK Cell Therapy Picture 1
Figure Global NK Cell Therapy Market Size (M USD) Status and Outlook (2014-2025) 3
Table Global Market NK Cell Therapy Revenue (M USD) Comparison by Regions 2019-2025 3
Figure Global NK Cell Therapy Market Share by Regions (2014-2019) 4
Figure North America NK Cell Therapy Market Size (M USD) and Growth Rate (2014-2025) 4
Figure Europe NK Cell Therapy Market Size (M USD) and Growth Rate (2014-2025) 5
Figure Asia NK Cell Therapy Market Size (M USD) and Growth Rate (2014-2025) 5
Figure Rest of World NK Cell Therapy Market Size (M USD) and Growth Rate (2014-2025) 6
Table Global NK Cell Therapy Revenue (M USD) and Growth Rate Comparison by Type (2019-2025) 7
Figure Global NK Cell Therapy Market Share by Type in 2018 & 2025 7
Figure NK Cell Therapies Market Size (M USD) and Growth Rate (2014-2019) 8
Figure NK Cell Directed Antibodies Market Size (M USD) and Growth Rate (2014-2019) 9
Table Global NK Cell Therapy Market Size (M USD) Comparison by Application (2019-2025) 9
Figure Global NK Cell Therapy Market Share by Application in 2018 & 2025 10
Figure NK Cell Therapy Market Size (M USD) and Growth Rate in Cancer (2014-2019) 11
Figure NK Cell Therapy Market Size (M USD) and Growth Rate in Gastrointestinal Diseases (2014-2019) 12
Table Global NK Cell Therapy Revenue (M USD) by Players (2018-2019) 13
Table Global NK Cell Therapy Revenue Market Share by Players (2018-2019) 14
Figure Global NK Cell Therapy Market Size Share by Players in 2018 15
Figure Global NK Cell Therapy Market Size Share by Players in 2019 16
Table Global NK Cell Therapy Manufacturers Market Concentration Ratio 16
Figure Global Top 5 Players NK Cell Therapy Market Share in 2018 17
Figure Global Top 10 Players NK Cell Therapy Market Share in 2018 17
Table NK Cell Therapy Key Players Product/Service 17
Table Nektar Therapeutics Basic Information List 20
Table Bempegaldesleukin(NKTR-214)Pipeline 21
Table Revenue (M USD) in NK Cell Therapy Business of Nektar Therapeutics (2018-2019) 23
Table Nektar Therapeutics Recent Developments 24
Table Innate Pharma SA Basic Information List 24
Figure Mechanism of Action of Anti-NKG2A Picture 25
Table Revenue (M USD) in NK Cell Therapy Business of Innate Pharma SA (2018-2019) 27
Table Innate Pharma SA Recent Developments 27
Table Affimed NV Basic Information List 27
Table Revenue (M USD) in NK Cell Therapy Business of Affimed NV (2018-2019) 29
Table Affimed NV Recent Developments 29
Figure Affimed NV Recent Developments 30
Table Chipscreen Biosciences Basic Information List 30
Figure Chidamide Picture 31
Table Revenue (M USD) in NK Cell Therapy Business of Chipscreen Biosciences (2018-2019) 32
Table Fate Therapeutics Basic Information List 32
Table Revenue (M USD) in NK Cell Therapy Business of Fate Therapeutics (2018-2019) 34
Table Fate Therapeutics Recent Developments 34
Table Glycostem Therapeutics Basic Information List 34
Figure Phase I Study of oNKord 36
Table Revenue (M USD) in NK Cell Therapy Business of Glycostem Therapeutics (2018-2019) 36
Table Dragonfly Therapeutics Basic Information List 37
Table Revenue (M USD) in NK Cell Therapy Business of Dragonfly Therapeutics (2018-2019) 38
Figure Dragonfly Therapeutics Recent Developments 38
Table Kiadis Pharma Basic Information List 38
Table Revenue (M USD) in NK Cell Therapy Business of Kiadis Pharma (2018-2019) 39
Table NantWorks Basic Information List 40
Table Revenue (M USD) in NK Cell Therapy Business of NantWorks (2018-2019) 42
Table NantWorks Recent Developments 42
Table Nkarta Therapeutics Basic Information List 42
Table Revenue (M USD) in NK Cell Therapy Business of Nkarta Therapeutics (2018-2019) 44
Table Fortress Biotech Basic Information List 44
Table Revenue (M USD) in NK Cell Therapy Business of Fortress Biotech (2018-2019) 45
Table Global NK Cell Therapy Market Size by Application (2014-2019) (M USD) 47
Table Global NK Cell Therapy Market Share by Application (2014-2019) 47
Figure Global NK Cell Therapy Revenue Market Share by Application (2014-2019) 48
Figure Global NK Cell Therapy Market Size Share by Application in 2018 48
Table Global NK Cell Therapy Market Growth by Application (2014-2019) 49
Figure Global NK Cell Therapy Market Growth by Application (2014-2019) 49
Figure North America NK Cell Therapy Market Size and Growth Rate (2014-2019) (M USD) 50
Table North America NK Cell Therapy Market Size by Players (2018-2019) (M USD) 50
Table North America NK Cell Therapy Market Size Share by Players (2018-2019) 51
Figure North America NK Cell Therapy Market Size Share by Players in 2018 51
Table North America NK Cell Therapy Market Size by Application (2014-2019) (M USD) 52
Table North America NK Cell Therapy Market Size Share by Application (2014-2019) 52
Figure North America NK Cell Therapy Market Size Share by Application in 2018 52
Figure Europe NK Cell Therapy Market Size and Growth Rate (2014-2019) (M USD) 53
Table Europe NK Cell Therapy Market Size by Players (2018-2019) (M USD) 53
Table Europe NK Cell Therapy Market Size Share by Players (2018-2019) 54
Figure Europe NK Cell Therapy Market Size Share by Players in 2018 54
Table Europe NK Cell Therapy Market Size by Application (2014-2019) (M USD) 54
Table Europe NK Cell Therapy Revenue Market Share by Application (2014-2019) 55
Figure Europe NK Cell Therapy Market Size Share by Application in 2018 55
Figure Asia NK Cell Therapy Market Size and Growth Rate (2014-2019) (M USD) 56
Table Asia NK Cell Therapy Market Size by Players (2018-2019) (M USD) 56
Figure Asia NK Cell Therapy Market Size Share by Players in 2018 57
Table Asia NK Cell Therapy Market Size by Application (2014-2019) (M USD) 57
Table Asia NK Cell Therapy Revenue Market Share by Application (2014-2019) 57
Figure Asia NK Cell Therapy Market Size Share by Application in 2018 58
Figure Rest of World NK Cell Therapy Market Size and Growth Rate (2014-2019) (M USD) 59
Table Rest of World NK Cell Therapy Market Size by Application (2014-2019) (M USD) 59
Table Rest of World NK Cell Therapy Revenue Market Share by Application (2014-2019) 60
Figure Rest of World NK Cell Therapy Market Size Share by Application in 2018 60
Table Global NK Cell Therapy Market Size by Type (2014-2019) (M USD) 61
Table Global NK Cell Therapy Market Share by Type (2014-2019) 61
Figure Global NK Cell Therapy Revenue Market Share by Type (2014-2019) 61
Figure Global NK Cell Therapy Market Size Share by Type in 2018 62
Table Global NK Cell Therapy Market Growth by Type (2014-2019) 62
Figure Global NK Cell Therapy Market Growth by Type (2014-2019) 63
Figure Global NK Cell Therapy Market Size and Growth Rate (Value) (2019-2025) (M USD) 66
Table Global NK Cell Therapy Market Size by Regions (2019-2025) (M USD) 66
Table Global NK Cell Therapy Market Share by Regions (2019-2025) 67
Figure Global NK Cell Therapy Market Size Share by Regions (2019-2025) 67
Figure Global NK Cell Therapy Market Size Share by Regions in 2025 68
Figure North America NK Cell Therapy Revenue (M USD) and Growth Rate (2019-2025) 69
Figure Europe NK Cell Therapy Revenue (M USD) and Growth Rate (2019-2025) 70
Figure Asia NK Cell Therapy Revenue (M USD) and Growth Rate (2019-2025) 71
Figure Rest of World NK Cell Therapy Revenue (M USD) and Growth Rate (2019-2025) 72
Table Global NK Cell Therapy Market Size by Application (2019-2025) (M USD) 72
Table Global NK Cell Therapy Market Share by Application (2019-2025) 72
Figure Global NK Cell Therapy Market Share by Application (2019-2025) 73
Figure Global NK Cell Therapy Market Size by Application in 2025 73
Table Global NK Cell Therapy Market Size by Type (2019-2025) (M USD) 74
Figure Global NK Cell Therapy Market Size by Type (2019-2025) 74
Figure Global NK Cell Therapy Market Size by Type in 2025 75
Table Market Top Trends 76
Figure Porter's Five Forces Analysis 78
Table NK Cell Developers Analysis 78
Table Research Programs/Design for This Report 81
Figure Bottom-up and Top-down Approaches for This Report 83
Figure Data Triangulation 84
Table Key Data Information from Secondary Sources 85
Table Key Data Information from Primary Sources 86


Request sample If you need any reports sample, just let us know.